IUHSA
ANIP icon

Itau Unibanco Holding S.A.’s ANI Pharmaceuticals ANIP Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,037
Closed -$42K – 148
2020
Q1 		$42K Sell
1,037
-842
-45% -$44.8K ﹤0.01% 309
2019
Q4 		$116K Buy
+1,879
New +$124K 0.01% 464

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Itau Unibanco Holding S.A.'s ANIP Position: Q2 2020 in Review

Itau Unibanco Holding S.A. sold out of ANI Pharmaceuticals (ANIP) in Q2 2020, closing a stake of 1,037 shares — an estimated $42K sold.

Itau Unibanco Holding S.A. first reported a position in ANIP in Q4 2019 and held it in 2 quarters. The position peaked at $116K in Q4 2019. 134 funds tracked by Wall St. Rank hold ANIP as of Q2 2020.

  • Itau Unibanco Holding S.A. reported no remaining ANI Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,037 ANI Pharmaceuticals shares in Q2 2020, an estimated $42K.
  • Itau Unibanco Holding S.A. first reported a position in ANI Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Itau Unibanco Holding S.A.'s ANI Pharmaceuticals position peaked at $116K in Q4 2019.
  • 134 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2020.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2020, filed 14 Aug 2020.